We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.13B
AUM Growth
-$145M
Cap. Flow
-$178M
Cap. Flow %
-8.34%
Top 10 Hldgs %
25.78%
Holding
1,594
New
34
Increased
419
Reduced
857
Closed
284

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$6.09M
2
AAPL icon
Apple
AAPL
+$5.83M
3
AMGN icon
Amgen
AMGN
+$5.16M
4
MSFT icon
Microsoft
MSFT
+$4.73M
5
ABBV icon
AbbVie
ABBV
+$4.26M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$5.44M
2
SLB icon
SLB Ltd
SLB
+$3.68M
3
FCX icon
Freeport-McMoran
FCX
+$3.13M
4
CVX icon
Chevron
CVX
+$2.97M
5
DUK icon
Duke Energy
DUK
+$2.44M

Sector Composition

Rank Sector Weight
1 Healthcare 31.2%
2 Technology 14.8%
3 Energy 7.96%
4 Financials 7.89%
5 Communication Services 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$162B
$113M 5.31%
1,064,073
+62,234
+6% +$6.09M
AMGN icon
2
Amgen
AMGN
$198B
$75.1M 3.52%
534,346
+39,540
+8% +$5.16M
ABBV icon
3
AbbVie
ABBV
$448B
$59.8M 2.8%
1,034,794
+76,797
+8% +$4.26M
BIIB icon
4
Biogen
BIIB
$29.2B
$55M 2.58%
166,253
+12,020
+8% +$3.96M
AAPL icon
5
Apple
AAPL
$4.79T
$53.5M 2.51%
2,124,464
+237,524
+13% +$5.83M
CELG
6
DELISTED
Celgene Corp
CELG
$53.4M 2.5%
563,029
+40,099
+8% +$3.62M
INTC icon
7
Intel
INTC
$516B
$38.3M 1.79%
1,099,638
+23,673
+2% +$802K
GOOG icon
8
Alphabet (Google) Class C
GOOG
$4.17T
$37.4M 1.75%
1,288,769
+122,536
+11% +$3.54M
MSFT icon
9
Microsoft
MSFT
$2.9T
$34.2M 1.6%
736,647
+106,097
+17% +$4.73M
JNJ icon
10
Johnson & Johnson
JNJ
$615B
$30.6M 1.43%
287,077
+39,203
+16% +$4.07M
XOM icon
11
ExxonMobil
XOM
$640B
$26.8M 1.26%
285,393
-54,634
-16% -$5.44M
ALXN
12
DELISTED
Alexion Pharmaceuticals
ALXN
$23.1M 1.08%
139,432
+9,630
+7% +$1.58M
META icon
13
Meta Platforms (Facebook)
META
$1.59T
$20.1M 0.94%
254,122
+23,815
+10% +$1.75M
REGN icon
14
Regeneron Pharmaceuticals
REGN
$68.3B
$19.2M 0.9%
53,317
-289
-0.5% -$96.9K
PFE icon
15
Pfizer
PFE
$141B
$18.9M 0.88%
673,433
+90,787
+16% +$2.55M
VRTX icon
16
Vertex Pharmaceuticals
VRTX
$120B
$18.9M 0.88%
168,126
+13,893
+9% +$1.32M
AMZN icon
17
Amazon
AMZN
$2.63T
$18.4M 0.86%
1,138,800
+89,040
+8% +$1.48M
MRK icon
18
Merck
MRK
$315B
$17.4M 0.82%
307,972
+39,742
+15% +$2.23M
ILMN icon
19
Illumina
ILMN
$28.9B
$15.7M 0.73%
98,276
+13,624
+16% +$2.28M
CVX icon
20
Chevron
CVX
$384B
$15.5M 0.73%
130,110
-23,305
-15% -$2.97M
SLB icon
21
SLB Ltd
SLB
$71.3B
$13M 0.61%
127,630
-33,738
-21% -$3.68M
WFC icon
22
Wells Fargo
WFC
$262B
$12.1M 0.57%
232,890
+23,199
+11% +$1.19M
CMCSA icon
23
Comcast
CMCSA
$84B
$11.8M 0.55%
439,186
+48,262
+12% +$1.32M
CSCO icon
24
Cisco
CSCO
$442B
$11.5M 0.54%
456,732
+41,786
+10% +$1.05M
JPM icon
25
JPMorgan Chase
JPM
$926B
$11.4M 0.54%
189,912
+19,220
+11% +$1.12M
1
2 3 4 5

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
APSPRSPT
Arizona Public Safety Personnel Retirement System (PSPRS) Trust Phoenix, Arizona $2.72B AUM 6.25% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Profund Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Profund Advisors held 1,594 positions worth $2.13B, down 6.4% from $2.28B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Profund Advisors withdrew a net $178M in Q3 2014, closing 284 positions and reducing 857 holdings. Its most notable exit was OPENTABLE,INC COMMON STOCK, an estimated $1.69M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 25% a quarter earlier, followed by Technology and Energy.

Against the trend, Profund Advisors opened a new position in Puma Biotechnology worth $3.06M.

  • Profund Advisors's largest Q3 2014 buy was Puma Biotechnology: 12,834 shares worth $3.06M.
  • Profund Advisors added most to Gilead Sciences in Q3 2014, an estimated $6.09M increase.
  • Profund Advisors's biggest Q3 2014 reduction was ExxonMobil, cutting an estimated $5.44M.
  • Profund Advisors fully exited OPENTABLE,INC COMMON STOCK in Q3 2014, selling an estimated $1.69M.
  • Profund Advisors's ten largest holdings make up 26% of its $2.13B portfolio in Q3 2014.
  • Profund Advisors opened 34 new positions and closed 284 in Q3 2014.
  • Profund Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.13B.

Based on Profund Advisors's 13F filing for Q3 2014, filed 6 Nov 2014.